- Report
- July 2023
- 124 Pages
Global
From €3798EUR$3,950USD£3,258GBP
- Report
- March 2020
- 161 Pages
Global
From €1322EUR$1,375USD£1,134GBP
€2644EUR$2,750USD£2,268GBP
- Report
- December 2018
- 22 Pages
Canada
From €4803EUR$4,995USD£4,120GBP
- Report
- December 2018
- 22 Pages
Brazil
From €4803EUR$4,995USD£4,120GBP
- Report
- December 2018
- 28 Pages
Australia
From €4803EUR$4,995USD£4,120GBP
- Report
- December 2018
- 22 Pages
Japan
From €4803EUR$4,995USD£4,120GBP
- Report
- December 2018
- 21 Pages
India
From €4803EUR$4,995USD£4,120GBP
- Report
- December 2018
- 42 Pages
United States
From €4803EUR$4,995USD£4,120GBP
- Report
- December 2018
- 21 Pages
China
From €4803EUR$4,995USD£4,120GBP
- Report
- December 2018
- 22 Pages
South Korea
From €4803EUR$4,995USD£4,120GBP
- Report
- December 2018
- 21 Pages
Spain
From €4803EUR$4,995USD£4,120GBP
- Report
- December 2018
- 22 Pages
Germany
From €4803EUR$4,995USD£4,120GBP
- Report
- February 2024
- 84 Pages
Global
From €3500EUR$3,899USD£3,108GBP
- Report
- December 2018
- 22 Pages
Mexico
From €4803EUR$4,995USD£4,120GBP
- Report
- December 2018
- 23 Pages
France
From €4803EUR$4,995USD£4,120GBP
- Report
- December 2018
- 24 Pages
United Kingdom
From €4803EUR$4,995USD£4,120GBP
- Report
- December 2018
- 21 Pages
Russia
From €4803EUR$4,995USD£4,120GBP
- Report
- December 2018
- 21 Pages
Italy
From €4803EUR$4,995USD£4,120GBP
Implantable remote patient monitoring devices are an advanced subset of wearable technology designed to provide continuous health monitoring and diagnostics from within the body. These devices include a variety of sensors and other medical implants that track vital signs and bodily functions, and they are particularly useful for monitoring chronic conditions such as heart disease, diabetes, and respiratory disorders. They differ from other wearable technologies by being placed inside the patient's body, often providing more accurate and real-time data for healthcare providers.
Implantable monitoring devices communicate with external receivers or smart technologies, allowing for real-time health analytics and patient management. The integration with telehealth services facilitates timely medical interventions and improves patient outcomes by allowing healthcare providers to make informed decisions based on the data transmitted by these devices. This market aligns with the increasing trend towards personal healthcare management and the demand for discrete and continuous monitoring solutions without the need for active patient involvement.
**Companies in the Market:**
- Medtronic
- Boston Scientific
- Abbott Laboratories
- BIOTRONIK
- Philips Healthcare
- GE Healthcare
- CardioMEMS (acquired by Abbott)
- St. Jude Medical (now part of Abbott)
- Dexcom
- Proteus Digital Health Show Less Read more